AbbVie to Build $1.4B Manufacturing Plant in NC

AbbVie Commits $1.4 Billion to New U.S. Facility

Pharmaceutical giant AbbVie has announced its largest-ever single-campus capital investment, dedicating $1.4 billion to construct a new manufacturing facility in Durham, North Carolina. The project is set to begin in 2026.

Strategic Expansion into North Carolina

The 185-acre campus will focus on producing medicines for immunology, neuroscience, and oncology. This move is part of AbbVie's broader $100 billion commitment to U.S. research, development, and capital investments over the next decade.

Economic and Labor Market Impact

The project is expected to create 734 permanent jobs over four years, including roles for engineers, scientists, and technicians. Additionally, the construction phase will generate over 2,000 temporary jobs, boosting the local economy significantly.

Future Outlook and Technological Integration

Scheduled for completion by late 2028, the Durham facility will integrate advanced manufacturing technologies and artificial intelligence. This investment signals AbbVie's confidence in long-term growth and its commitment to strengthening its U.S. manufacturing footprint.

FAQ

Q: What is the total investment for AbbVie's new plant?
A: The total investment is $1.4 billion.

Q: How many jobs will the new AbbVie facility create?
A: It will create 734 permanent jobs over four years and over 2,000 construction jobs.

Source: Investing.com